Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
57.79
-2.41 (-4.00%)
Aug 26, 2026, 4:00 PM EDT

SHA:688192 Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for SHA:688192 stock have an average target of ¥83.00, which predicts a 43.62% increase from the current stock price of 57.79.

Price Target: ¥83.00 (+43.62%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥83.00¥83.00¥83.00¥83.00
Change+43.62%+43.62%+43.62%+43.62%

Analyst Ratings

The average analyst rating for SHA:688192 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJan '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy333321
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total444432

Financial Forecast

Revenue This Year
3.17B
from 801.14M
Increased by 295.75%
Revenue Next Year
1.77B
from 3.17B
Decreased by -44.28%
EPS This Year
6.43
from -1.89
EPS Next Year
0.66
from 6.43
Decreased by -89.74%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
10.29M-91.29M359.90M801.14M3.17B
Revenue Growth
-62.95%--294.25%122.60%295.75%
Gross Profit
-2.65M-3.65M83.63M350.58M766.91M3.03B
Gross Margin
-25.72%-91.61%97.41%95.73%95.70%
Operating Income
-674.37M-792.55M-1.16B-972.43M-819.97M1.50B
Net Income
-669.88M-736.00M-1.11B-845.96M-764.05M1.24B
EPS
-----1.896.43
Forward PE
-----8.99
Free Cash Flow
-234.15M-468.46M-596.90M-427.28M-533.00M2.99B
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High5.2B
Avg3.2B
Low1.2B

Revenue Growth

Revenue Growth202620272028
High
547.2%
Avg
295.8%
Low
44.3%

EPS Forecast

EPS202620272028
High6.43
Avg6.43
Low6.43

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-